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DNA methylation of CpG dinucleotides by DNA methyltransferase 1 is implicated in the regulation of transcription and,
in particular, the transcription of imprinted genes. Although the oocyte-specific form of Dnmt1 (Dnmt1o) possesses a
functional nuclear localization signal, it is predominantly localized in the cytoplasm of the oocyte and preimplantation
mouse embryo but undergoes a transient nuclear localization during the eight-cell stage, when the embryos undergo
compaction. We report here that Dnmt1o is likely retained in the cytoplasm by an active process, since ;70% of DNA
methyltransferase activity is retained following permeabilization procedures that result in the release of ;75% of
oocyte/embryo protein. Treatment of the embryos with agents that disrupt either microfilaments or microtubules has little,
if any, effect on the retention of Dnmt1o in permeabilized embryos. While Dnmt1o does not colocalize with either
mitochondria or endoplasmic reticulum, it does colocalize with annexin V, which is known to interact with Dnmt1o. We
also report that the timing of nuclear entry of Dnmt1o during the eight-cell stage is independent of DNA replication,
transcription, and protein synthesis, as well as compaction, cell contact, and cytokinesis. The time of nuclear entry,
therefore, appears linked to the time following fertilization, which suggests that a molecular clock governs the time of
nuclear import. © 2002 Elsevier Science (USA)
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The faithful methylation of cytosine residues in the CpG
dinucleotides of nuclear DNA is crucial to mammalian
development (Bestor, 2000; Jones et al., 1998; Nan et al.,
1997). While DNA hypermethylation is typically associated
with gene repression (Jones et al., 1998; Nan et al., 1997),
this modification is postulated to be important for the
suppression of retroposon transcription and the regulation
of gene expression, particularly that which controls
genomic imprinting and X inactivation (Bestor, 2000). Fur-
thermore, perturbation of normal DNA methylation pat-
terns is associated with disease (Jones et al., 1998).
At least four DNA methyltransferase (Dnmt) genes have
been identified that encode the de novo and maintenance
methylase activities that are observed in mammals. The
first characterized Dnmt gene, Dnmt1, is predominantly
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All rights reserved.responsible for the maintenance of cellular methylation
patterns, but it also exhibits de novo activity (Yoder et al.,
1997). Two additional genes, Dnmt3a and Dnmt3b, encode
methyltransferases with de novo activity (Okano et al.,
1998). Deletion of these genes in mice results in extensive
perturbations in DNA methylation patterns and embryonic
lethality (Li et al., 1992; Okano et al., 1999). Likewise, the
significance of proper DNA methylation in humans is
underscored by the observation that ICF syndrome, which
is characterized by immunodeficiency, centromere instabil-
ity, and facial anomalies, is caused by mutations in the
DNMT3B gene (Xu et al., 1999).
Dnmt1 is a complex protein harboring an N-terminal
domain that suppresses de novo methylation and a
C-terminal catalytic domain that is similar to bacterial
methyltransferases (Bestor, 1992, 2000). The N-terminal
domain also contains nuclear localization signals and a
sequence that directs the enzyme to replication foci (Leon-
hardt et al., 1992). In addition to Dnmt1s, the somatic form
of Dnmt1 that is present in most cells, the Dnmt1 gene
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1998). Dnmt1p is found in pachytene spermatocytes; its 59
exon interferes with translation, thereby preventing pro-
duction of the protein during male germ cell meiosis. In
contrast, very high levels of an N-terminal truncated active
Dnmt1o protein are translated from the growing oocyte-
specific transcript. The Dnmt1o protein persists until the
blastocyst stage of development, when it is subsequently
replaced by Dnmt1s (Mertineit et al., 1998). Dnmt1o exhib-
its an unusual localization pattern during female germ cell
and preimplantation mouse development (Carlson et al.,
1992; Mertineit et al., 1998). In the growing oocyte, the
protein is predominantly nuclear, but it is subsequently
localized to the cytoplasm. Dnmt1o persists in the cyto-
plasm until the blastocyst stage with one exception: At the
eight-cell stage, the protein is transiently localized to the
nucleus. This cytoplasmic localization is surprising given
the important role Dnmt1 is proposed to play in maintain-
ing global methylation patterns. Its localization at replica-
tion forks in somatic cells aptly positions the enzyme to
propagate this epigenetic modification to the newly repli-
cated DNA. While evidence suggests that Dnmt1o is ac-
tively maintained in the cytoplasm (Cardoso and Leon-
hardt, 1999), little is currently known about how this
localization is controlled.
We report here that Dnmt 1o is retained following per-
meabilization procedures that release more than 75% of
total soluble protein. Moreover, the enzyme is still retained
following treatments that disrupt either microfilaments or
microtubules. Dnmt1o does not colocalize with either
mitochondria or endoplasmic reticulum, but may colocal-
ize with annexin V. In addition, the movement of Dnmt1o
from the cytoplasm to the nucleus is independent of DNA
replication, transcription, and protein synthesis, as well as
compaction, cell contact, and cytokinesis. Thus, the move-
ment into the nucleus appears to be a function of the time
following fertilization.
MATERIALS AND METHODS
Oocyte and Embryo Collection and Culture
Oocytes were collected from PMSG-primed CF1 mice (Harlan) in
Minimal Essential Medium supplemented with 3 mg/ml PVP and
0.2 mM IBMX as previously described (Schultz et al., 1983).
Two-cell, four-cell, and eight-cell embryos were flushed from the
oviduct/uterus of PMSG and hCG-primed mice mated to B6D2F1
males (The Jackson Laboratory) as previously described (Manejwala
et al., 1986). Embryos were cultured in KSOM 1 amino acids
(Erbach et al., 1994; Ho et al., 1995) in 5% CO2:5% O2:90% N2 at
37°C. Embryos were cultured in medium containing either 3 mg/ml
of aphidicolin or 100 mM fluorodeoxyuridine to inhibit DNA
replication, 0.5 mg/ml cytochalasin D to inhibit cytokinesis, 10 mM
nocodazole to inhibit microtubule polymerization, 24 mg/ml
a-amanitin to inhibit transcription, or 10 mg/ml cycloheximide to
inhibit protein synthesis. Further details are described in Results.
© 2002 Elsevier Science (USAIsolation of Individual Eight-Cell Blastomeres
Uncompacted eight-cell embryos were isolated 67 h post-hCG.
The zona pellucida was removed by a brief treatment with acid
Tyrode solution, pH 2.5, and the embryos were then cultured in
calcium-free KSOM for 30 min. Individual eight-cell blastomeres
(1/8 blastomeres) were then isolated by gentle manipulation with a
mouth-operated micropipet. Single 1/8 blastomeres were then
cultured for 12 h in either calcium-containing or calcium-free
KSOM.
Generation of Cytoskeletal Preparations
Cytoskeletal preparations of embryos were generated by placing
the embryos in intracellular buffer (ICB; 100 mM KCl, 5 mM
MgCl2, 3 mM EGTA, 20 mM Hepes, pH 6.8) containing 1% Triton
X-100. After 10 min, the embryos were then washed through three
drops of PBS containing 3 mg/ml PVP. These preparations were
used for either confocal microscopy or Dnmt activity assay.
Immunocytochemical Detection of Dnmt1o and
Annexin V
Embryo fixation, permeabilization, and laser-scanning confocal
microscopy were performed as previously described (Doherty et al.,
2000); all images in each figure were taken at the same settings.
The Dnmt1 antibody PATH52 was the generous gift of Dr. Timo-
thy Bestor. Although this antibody recognizes both the Dnmt1o
and Dnmt1s isoforms, Dnmt1s is not detected in the oocyte and
preimplantation embryo, i.e., only Dnmt1o is expressed during this
time (Howell et al., 2001), and hence the observed staining is solely
attributable to Dnmt1o. Saved images were cropped in Photoshop
3.0 and then assembled in Canvas 6.0. We have noted that there is
a certain degree of variability from experiment to experiment in the
appearance of the cytoplasmic punctate staining pattern and the
intensity of the signal. The basis for this variability is not known.
To detect annexin V, oocytes or four-cell embryos were freshly
collected from PMSG/hCG-primed CF1 mice then paraformalde-
hyde fixed for 1 h. The cells were next incubated for 1 h with 1:250
dilution of an antibody to annexin V (Santa Cruz Biotechnology;
cat. no. sc-1928) and then examined by laser-scanning confocal
microscopy. Specificity of staining was established by demonstrat-
ing that incubating the antibody with an excess of annexin V
peptide (Santa Cruz Biotechnology; cat. no. sc-1928p) abolished
detecting any signal (data not shown). Saved images were cropped
in Photoshop 3.0 and then assembled in Canvas 6.0.
DNA Methyltransferase Assay
Total DNA methyltransferase activity was performed as previ-
ously described (Doherty et al., 2000); ten embryos were used for
each assay, which was conducted in triplicate.
Metabolic Radiolabeling of Embryos
Embryo proteins were metabolically radiolabeled by incubating
embryos in KSOM containing 1 mCi/ml of [35S]methionine (1500
Ci/mmole; Amersham) for 2 h in 5% CO2:5% O2:90% N2 at 37°C.
The total amount of acid-insoluble radioactivity material was
determined as previously described (Poueymirou and Schultz,
1987).
). All rights reserved.
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Reticulum
Freshly collected eight-cell embryos were cultured for 1 h in
KSOM supplemented with MitoTracker Green FM (200 nM final
concentration) (Molecular Probes; cat. no. M-7514) or ER Tracker
(200 nM final concentration) (Molecular Probes; cat. no. M-7514).
The embryos were then fixed and processed for Dnmt1o detection
by laser-scanning confocal microscopy as described above.
RESULTS
Cytoplasmic Retention of Dnmt1o
In somatic cells, Dnmt1s is localized in the nucleus at
replication forks (Leonhardt et al., 1992). Presumably, this
promotes efficient methylation of the appropriate cytosine
residues on the newly replicated strands and hence main-
tains this epigenetic modification. In stark contrast is the
observation that the majority of Dnmt1o is localized in the
cytoplasm of the oocyte and preimplantation embryo prior
to the eight-cell stage. This observation is especially inter-
esting in light of the finding that when the oocyte-specific
form of Dnmt1 is expressed in somatic cells, it is located in
the nucleus (Cardoso and Leonhardt, 1999). Taken together,
these results suggest that the preimplantation embryo may
be unique in its ability to retain Dnmt1o in the cytoplasm.
Although the punctate staining patterning (Carlson et al.,
1992; Cardoso and Leonhardt, 1999; Doherty et al., 2000) is
consistent with a cytoplasmic retention mechanism, it is
possible that Dnmt1o freely diffuses into the nucleus but
then is rapidly and efficiently exported to the cytoplasm.
To ascertain whether Dnmt1o was indeed retained in the
cytoplasm and not freely diffusible, four-cell embryos were
treated with 1% Triton X-100, and the remaining insoluble
material was then assayed for DNA methyltransferase
activity. This treatment released the majority of soluble
protein, since following permeabilization of metabolically
radiolabeled embryos ;75% of the acid-insoluble radioac-
tive material was released. Nevertheless, ;70% of the total
amount of DNA methyltransferase activity in the embryos
was retained following this treatment (Fig. 1). This residual
activity was fairly tightly associated with these prepara-
tions, since it remained for at least 20 min following Triton
X-100 treatment. It was unlikely that either microfilaments
or microtubules were involved in the retention mechanism,
since similar amounts of DNA methyltransferase activity
remained associated with the Triton X-100-insoluble mate-
rial when the embryos were initially treated for 2 h with
either cytochalasin D (% retained, 79 6 8) or nocodazole (%
retained, 73 6 4), which disrupt microfilaments and micro-
tubules, respectively.
The presence of an insoluble DNA methyltransferase
activity following Triton X-100 treatment was confirmed
by laser-scanning confocal microscopy (Figs. 2A and 2A9).
Dnmt1o was readily observed in the Triton X-100-treated
embryos, and, if anything, the signal intensity was some-
what higher than the untreated controls. While the reason
© 2002 Elsevier Science (USAfor this is not known, it could be attributed to greater access
of the primary antibody as a result of the treatment. It
should also be noted that Dnmt1o, which was present in
the nuclei of the control nonpermeabilized eight-cell em-
bryos, was absent from the nuclei of the permeabilized
embryos. The absence of Dnmt1o in the nuclei of the
permeabilized embryos confirmed that the nuclear enve-
lope was indeed permeabilized, and moreover suggested
that any association of Dnmt1o with nuclear components
was weak. Last, consistent with the aforementioned result
that neither microfilaments nor microtubules seemed in-
volved in the cytoplasmic retention of DNA methyltrans-
ferase activity was the observation that similar amounts of
Dnmt1o were retained in embryos treated with either
cytochalasin D (or latrunculin A, which disrupts microfila-
ments by a different mechanism; Ayscough, 1998) or no-
codazole prior to Triton X-100 treatment (Figs. 2B–2C9).
Similar results were also observed when oocytes were
treated with either cytochalasin D or nocodazole prior to
Triton X-100 treatment (data not shown).
The punctate staining pattern observed for Dnmt1o and
its cytoplasmic retention could be due to its association
with the mitochondria or endoplasmic reticulum. To deter-
mine whether such an association existed, four-cell em-
bryos were stained with MitoTracker or ER Tracker, and
Dnmt1o was then localized by immunostaining in these
embryos. No apparent colocalization, however, was ob-
served (Figs. 3A–3C and 3D–3F).
The amino terminus of Dnmt1o can bind annexin V
(Ohsawa et al., 1996), which is a calcium-sensitive phos-
pholipid binding protein (Schlaepfer et al., 1987). Such an
interaction could account for the enhanced cortical
FIG. 1. Retention of Dnmt1o activity in Triton X-100-
permeabilized embryos. Dnmt1o activity (solid bars) or residual
amount of acid-insoluble radioactivity (open bars) in embryos
treated with Triton X-100 for the indicated times. The experiment
was conducted seven times. The data, which are expressed as the
percent of untreated embryos, are the mean 6 SEM. The errors are
too small to be observed for the open bars.Dnmt1o staining in oocytes and early cleavage-stage em-
). All rights reserved.
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tion. In fact, staining of either oocytes or four-cell embryos
for annexin V revealed a discernible colocalization of
Dnmt1o and annexin V (Figs. 3G–3I and 3J–3L). This
colocalization was also observed in eight-cell embryos, and
the annexin V present in the oocytes and embryos also
remained associated with Triton X-100-insoluble prepara-
tions (data not shown).
Role of Cell Contact in Dnmt1o Nuclear
Translocation
While Dnmt1o is retained in the cytoplasm during most
FIG. 2. Dnmt1o localization in permeabilized, nocodazole- and
medium containing either nocodazole or cytochalasin D for 2 h, p
chemical detection of Dnmt1o. (A–C) Unpermeabilized untreated c
(A9–C9) Permeabilized untreated control, nocodazole-, and cytocha
four times with at least five embryos in each treatment group. Shof preimplantation development, it is translocated to the
© 2002 Elsevier Science (USAnucleus during the eight-cell stage, i.e., during compaction.
This occurrence suggests a linkage between these two
events. Prior to compaction, the individual blastomeres of
the developing embryo are clearly discernible under the
light microscope (Levy et al., 1986). During compaction, the
blastomeres flatten on one another such that following
compaction it is difficult to delineate clearly the boundaries
between the blastomeres. Compaction, which is mediated
by the calcium-dependent cadherin E-cadherin (also called
uvomorulin) (Hyafil et al., 1980, 1981), is inhibited by
incubating embryos in calcium-free medium. Accordingly,
we examined the effect of inhibiting compaction on the
nuclear translocation of Dnmt1o.
chalasin-treated embryos. Eight-cell embryos were incubated in
abilized with Triton X-100, and then processed for immunocyto-
ol, nocodazole-, and cytochalasin D-treated embryos, respectively.
D-treated embryos, respectively. The experiment was performed
are representative photomicrographs.cyto
erme
ontr
lasinFour-cell embryos were cultured in calcium-free me-
). All rights reserved.
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259Localization of Dnmt1o in Preimplantation Embryodium, and Dnmt1o was detected in these uncompacted
embryos during and following the time that compaction
FIG. 3. Localization of Dnmt1o, mitochondria, endoplasmic reti
Tracker or ER Tracker. The cells were then processed for Dnmt
processed for simultaneous localization of both annexin V and D
embryos. (D–F) Localization of Dnmt1o and endoplasmic reticulum
oocytes. (J–L) Localization of Dnmt1o and annexin V in four-cell em
tion experiments were performed 4, 1, and 2 times, respectively, a
representative photomicrographs.occurred in the control embryos; there was no evidence of a
© 2002 Elsevier Science (USAnuclear localization of Dnmt1o in these four-cell embryos
(data not shown). As previously reported (Carlson et al.,
, and annexin V. Oocytes or embryos were incubated with Mito
munocytochemical localization. For annexin V, the cells were
1o. (A–C) Localization of Dnmt1o and mitochondria in four-cell
four-cell embryos. (G–I) Localization of Dnmt1o and annexin V in
os. The MitoTracker, ERTracker, and annexin V immunolocaliza-
least 10 embryos were examined in each experiment. Shown areculum
1o im
nmt
in
bry1992; Doherty et al., 2000), in control embryos cultured in
). All rights reserved.
260 Doherty, Bartolomei, and Schultzcalcium-containing medium, compaction was associated
with the translocation of Dnmt1o into the nucleus, fol-
lowed by exit of Dnmt1o by the morula stage. When the
embryos were cultured in calcium-free medium, a similar
nuclear translocation was observed during the eight-cell
stage, followed by an exit by the morula stage (Fig. 4). Thus,
the changes in cytoplasmic and nuclear localization of
Dnmt1o appeared uncoupled to compaction.
When compaction is inhibited by culture in calcium-free
medium, there still is a substantial amount of cell–cell
contact between the blastomeres. To minimize this as a
contributing factor, uncompacted eight-cell embryos were
disaggregated into 1/8 blastomeres that were then cultured
in isolation, i.e., in the absence of any cell contact. In these
experiments, there was no sign of Dnmt1o nuclear local-
ization in the donor uncompacted embryos (Fig. 5A). When
the control embryos had undergone compaction and
Dnmt1o was clearly localized in the nucleus, Dnmt1o
localization in the cultured 1/8 blastomeres was assayed
and also found to be nuclear (Fig. 5D). When the control
embryos reached the morula stage, Dnmt1o was localized
in the cytoplasm (Fig. 5C), as it was in the 1/8 blastomeres
that had now cleaved to form two 1/16 blastomeres (Fig.
FIG. 4. Effect of inhibiting compaction on Dnmt1o nuclear local
medium (A–C) or in calcium-free medium (D–F). Embryos were
embryos were uncompacted (A, D), compacted (B, E), or at the mor
the blastomeres, in contrast to the loose blastomere apposition in th
three times, and for each experiment, approximately five embryos
graphs.5E). This nuclear entry and exit of Dnmt1o also occurred
© 2002 Elsevier Science (USAwhen the 1/8 blastomeres were cultured in calcium-free
medium (data not shown).
Compaction can be induced prematurely by treating
four-cell embryos with biologically active phorbol esters or
diacylglyerols (Bloom, 1989; Winkel et al., 1990); the effect
is transient and persists for a few hours. We found that
treatment of four-cell embryos with TPA induced compac-
tion within 30 min and that there was no evidence for a
nuclear accumulation of Dnmt1o when the embryos were
examined 0.25, 0.5, 1.0, 3.0, 4.0, and 5.5 h later (data not
shown).
In toto, these results suggest that the temporal redistri-
bution of Dnmt1o that occurs between the four-cell and
morula stages is cell-autonomous and not linked with
compaction and cell contact.
Role of Transcription and Protein Synthesis in
Dnmt1o Nuclear Translocation
There are three periods of dramatic changes in gene
expression that occur during preimplantation development.
The first occurs during the maternal-to-embryonic transi-
tion during the two-cell stage, the second during the time of
on. Four-cell embryos were cultured in either calcium-containing
cessed for Dnmt1o immunocytochemical localization when the
tage (C, F). Note in the compacted embryos the tight apposition of
bryos cultured in calcium-free medium. The experiment was done
ach group were examined. Shown are representative photomicro-izati
pro
ula s
e em
in ecompaction at the eight-cell stage, and the third during the
). All rights reserved.
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261Localization of Dnmt1o in Preimplantation Embryomorula-to-blastocyst transition with the differentiation of
the trophectoderm cells and establishment of the totipotent
inner cell mass cells. In principle, the changes in gene
expression that occur prior to or during the eight-cell stage
could be involved in the nuclear translocation of Dnmt1o.
This possibility was assessed by examining the effect of
inhibiting transcription with a-amanitin or inhibiting the
synthesis of any newly synthesized proteins from such
expressed transcripts with cycloheximide.
Four-cell embryos were cultured in the presence of either
inhibitor, and Dnmt1o localization was assessed when the
embryos were chronologically at the eight-cell stage; inhib-
iting either transcription or protein synthesis prior to late
G2 inhibits cleavage to the eight-cell stage. Results of these
experiments indicated that Dnmt1o had translocated to the
nucleus (Fig. 6), and hence the translocation event was
independent of both transcription and protein synthesis.
Role of Cell Division in Dnmt1o Nuclear
Translocation
To ascertain whether the nuclear translocation of
Dnmt1o was linked to cell division, four-cell embryos were
cultured in cytochalasin D. Cytochalasin D inhibits cyto-
FIG. 5. Dnmt1o nuclear localization in 1/8 blastomeres. Single 1/
as described under Materials and Methods, and then cultured to
morula stage (C). Dnmt1o was localized in the nucleus of the 1/8 bl
and again resident in the cytoplasm at a time corresponding to the m
five embryos in each treatment group. Shown are representative pkinesis but not karyokinesis; the temporal sequence of the
© 2002 Elsevier Science (USAtreated embryo’s molecular development remains the same
as that of untreated cells (Pratt et al., 1981). Results of these
experiments clearly demonstrated that Dnmt1o was
present in the nuclei of the binucleate blastomeres that
were chronologically at the eight-cell stage and absent in
the nuclei of the binucleate blastomeres that were chrono-
logically at the morula stage (Fig. 7). Thus, these intracel-
lular movements are not linked to cytokinesis. In addition,
we found no evidence for a premature movement of
Dnmt1o into the nuclei of the cytochalasin D-treated
embryos (data not shown). As discussed below, this sug-
gests that the cytoplasmic retention of Dnmt1o was un-
likely mediated by microfilaments that are known to be
disrupted by the culture conditions employed (Pratt et al.,
1981).
The two major morphological transitions that occur
during preimplantation development, namely, compaction
and blastocoel formation, are independent of the proximal
two rounds of DNA replication (Dean and Rossant, 1984;
Manejwala et al., 1986). To examine the role of DNA
replication in the intercellular movements of Dnmt1o,
two-cell embryos were cultured in medium containing
aphidicolin, which inhibits replicative DNA polymerases
(Ikegami et al., 1978). If the two-cell embryos had com-
stomeres were obtained from uncompacted eight-cell embryos (A),
s when control embryos had either compacted (B) or reached the
ere (D) that was chronologically at the compacted eight-cell stage
la stage (E). The experiment was performed five times with at least
micrographs.8 bla
time
astom
orupleted S phase, they divided to and arrested at the four-cell
). All rights reserved.
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mained arrested at the two-cell stage. Strikingly, Dnmt1o
translocated into the nuclei of these aphidicolin-treated
FIG. 6. Effect of inhibiting transcription and translation on Dnm
containing either a-amanitin or cycloheximide and then process
embryos had reached the eight-cell stage and undergone compacti
embryos treated with cycloheximide. The experiment was perform
Shown are representative photomicrographs.
FIG. 7. Effect of inhibiting cytokinesis on Dnmt1o nuclear lo
cytochalasin D and then processed for immunocytochemical detec
reached the morula stage (C); Dnmt1o was mainly cytoplasmic in
cleavage-arrested four-cell embryos that were chronologically at
chronologically at the morula stage (E). The experiment was perf
Shown are representative photomicrographs.
© 2002 Elsevier Science (USAembryos at the same time that it was translocated in the
control embryos, i.e., when the treated embryos were chro-
nologically at the eight-cell stage (Fig. 8). Dnmt1o, how-
nuclear localization. Four-cell embryos were cultured in medium
r immunocytochemical detection of Dnmt1o when the control
) Control embryos, (B) embryos treated with a-amanitin, and (C)
hree times with at least three embryos in each treatment group.
ation. Four-cell embryos were cultured in medium containing
of Dnmt1o when the control embryos had either compacted (B) or
uncompacted eight-cell embryos (A). Dnmt1o was nuclear in the
compacted eight-cell stage (D) and cytoplasmic when they were
d two times with at least five embryos in each treatment group.t1o
ed fo
on. (Acaliz
tion
the
the
orme). All rights reserved.
263Localization of Dnmt1o in Preimplantation Embryoever, remained localized in the nucleus following further
culture and did not exit the nucleus, as was the case for the
untreated embryos. Similar results were observed when
DNA replication was inhibited with 5-fluorodeoxyuracil,
which inhibits DNA replication by a different mechanism
(Bolton et al., 1984; and data not shown). Results of these
experiments suggest that nuclear entry of Dnmt1o is a
time-dependent event.
DISCUSSION
Several lines of experimentation indicate that differential
DNA methylation is correlated with the expression of
imprinted genes. For example, a region 24 to 22 kb
upstream from the transcription start site of the paternal
copy of the H19 gene, which is not expressed, is hyperm-
ethylated relative to the maternal copy (Tremblay et al.,
1997), and deletion of this region on the paternal chromo-
some results in expression of the paternal allele (Thorvald-
sen et al., 1998). The ability of DNA-binding proteins, such
as MeCP2, to recruit histone deacetylases could provide the
mechanistic linkage between DNA methylation and repres-
sion of expression (Jones et al., 1998; Nan et al., 1998), since
histone acetylation generates a transcriptionally permissive
chromatin structure (Turner and O’Neill, 1995; Wolffe,
FIG. 8. Effect of inhibiting DNA replication on Dnmt1o nuclear
localization. Two-cell embryos were cultured in medium contain-
ing aphidicolin and then processed for immunocytochemical de-
tection of Dnmt1o when the control embryos had either compacted
(A) or reached the blastocyst stage (B). Dnmt1o was nuclear in the
cleavage-arrested two/four-cell embryos that were chronologically
at the compacted eight-cell stage (C) and remained nuclear when
they were chronologically at the blastocyst stage (D). The experi-
ment was performed three times with at least four embryos in each
treatment group. Shown are representative photomicrographs.1996).
© 2002 Elsevier Science (USAFollowing fertilization, a global demethylation initiates
in the one-cell embryo and continues up to the blastocyst
stage (Monk et al., 1987; Sanford et al., 1987), after which
time de novo methylation occurs. The cytoplasmic location
of Dnmt1o, despite the presence of a functional nuclear
localization signal (NLS) (Cardoso and Leonhardt, 1999;
Leonhardt et al., 1992), may facilitate this global demeth-
ylation, since it would not be able to provide a maintenance
function following each round of DNA replication. Re-
markably, the allele-specific differences in DNA methyl-
ation of imprinted genes survive the global demethylation
(Tremblay et al., 1997). Thus, the transient nuclear trans-
location that occurs during the eight-cell stage (Carlson et
al., 1992; Doherty et al., 2000) may perform a surveillance
function to maintain the differential methylation pattern of
imprinted genes, and consistent with this proposal is that
deletion of maternal Dnmt1o results in loss of the paternal
methylation pattern from one-half of the normally methyl-
ated paternal H19 genes following fertilization (Howell et
al., 2001). At earlier times in preimplantation development,
other DNA methyltransferase(s) may serve the mainte-
nance function (Howell et al., 2001).
While these observations suggest a role for the cytoplas-
mic retention of Dnmt1o and its transient nuclear localiza-
tion at the eight-cell stage in genomic imprinting, little is
known regarding the molecular basis for its cytoplasmic
retention and what regulates the timing of Dnmt1o’s
nuclear entry. Results described here suggest Dnmt1o is
retained in the cytoplasm, possibly by associating with
annexin V, rather than being free to enter the nucleus and
then actively exported, and that a molecular clock governs
the time for nuclear entry.
Results from a previous study (Cardoso and Leonhardt,
1999) also suggest that Dnmt1o is retained in the cytoplasm
by embryos despite the presence of an NLS, since a
Dnmt1o–b-galactose fusion protein is localized in the
nucleus when expressed in somatic cells. Moreover, incor-
poration of the SV40 NLS fails to direct a nuclear localiza-
tion of Dnmt1o when it is expressed in preimplantation
embryos. Last, overexpression of Dnmt1o–b-galactose fu-
sion protein in preimplantation mouse embryos results in
nuclear, as well as cytoplasmic, localization and suggests
that cytoplasmic retention is saturable. Our results confirm
and extend these observations by documenting that the
bulk of both Dnmt1o immunoreactive material and en-
zyme activity is retained following permeabilization condi-
tions that result in the release of the majority of oocyte/
embryo protein, i.e., Dnmt1o is retained, and not free to
diffuse, in the cytoplasmic compartment. Also consistent
with this interpretation is that embryos treated with lepto-
mycin B, which inhibits exportin 1/CRM1-mediated
nuclear export (Kudo et al., 1999), fail to evince any sign of
nuclear accumulation of Dnmt1o over the period of 0.5–5.5
h (unpublished observations); nuclear accumulation should
have been observed if Dnmt1o was free to enter the nucleus
and then actively exported via the exportin 1/CRM1 path-
way.
). All rights reserved.
264 Doherty, Bartolomei, and SchultzThe molecular basis for the cytoplasmic retention, how-
ever, remains enigmatic. Disruption of the cytoskeleton by
either microfilament or microtubule inhibitors does not
result in the release of either Dnmt1o activity or immuno-
reactive material in the permeabilized embryos. Disruption
of microtubules often leads to the collapse of the interme-
diate filament population around the nucleus, e.g., Franke
et al., 1978. The failure to observe any detectable redistri-
bution of Dnmt1o localization in nocodazole-treated em-
bryos minimizes an interaction with intermediate fila-
ments. Although the punctate Dnmt1o staining that we
and others (Cardoso and Leonhardt, 1999; Carlson et al.,
1992) observe suggests that Dnmt1o could associate with
an organelle, we observe no apparent colocalization with
either mitochondria or endoplasmic reticulum. Neverthe-
less, we do observe colocalization with annexin V, a protein
known to interact with Dnmt1o (Ohsawa et al., 1996). If a
physical interaction exists, however, it still does not ex-
plain the cytoplasmic retention of Dnmt1o, since when
Dnmt1o is expressed in somatic cells, which also express
annexin V, it localizes to the nucleus (Cardoso and Leon-
hardt, 1999). It will be of particular interest to ascertain the
localization of Dnmt1s, which contains an additional 118
amino acids at the amino terminus (Mertineit et al., 1998),
following expression in the oocyte/embryo. Retention of
Dnmt1s in the cytoplasm would suggest that there is some
unique quality of the oocyte/embryo cytoplasm that directs
Dnmt1 retention (e.g., an oocyte/embryo-specific anchoring
protein or posttranslational modification of Dnmt1),
whereas nuclear entry would suggest that the amino-
terminal sequence of Dnmt1s somehow prevents cytoplas-
mic retention.
The entry of Dnmt1o into the nucleus during the eight-
cell stage is independent of DNA replication, transcription,
translation, cell contact, and cytokinesis, since it occurs
when each of these processes is inhibited or disrupted.
Thus, the time of Dnmt1o’s entry into the nucleus seems
governed by a “molecular clock” that is uncoupled to these
aforementioned processes. In fact, a molecular clock ap-
pears to govern each of the three major developmental
transitions that occur during preimplantation development,
i.e., genome activation (Schultz, 1993), compaction (Levy et
al., 1986), and blastocoel formation (Dean and Rossant,
1984; Pratt et al., 1981), since each of these transitions
appears uncoupled to cell cycle progression and initiates
after a set period of time following fertilization. Although
one could envision a coupling of nuclear translocation of
Dnmt1o with compaction, such is not the case, since
Dnmt1o enters the nuclei of eight-cell embryos in which
compaction is prevented by either culture in calcium-free
medium or in individual 1/8 blastomeres. Consistent with
a dissociation of nuclear translocation from compaction is
that inducing premature compaction does not induce the
nuclear translocation. We also noted that, when protein
synthesis is inhibited starting at the four-cell stage, there is
no precocious entry of Dnmt1o prior to the eight-cell stage
(unpublished observations). This result minimizes the like-
© 2002 Elsevier Science (USAlihood that (1) the turnover of a protein involved in the
cytoplasmic retention of Dnmt1o governs the time of
nuclear entry of Dnmt1o, since it would be anticipated that
such a putative protein would turn over faster in the
absence of continual protein synthesis and (2) some pro-
tein(s) synthesized during the four-cell stage are required for
nuclear translocation. Although inhibiting protein synthe-
sis has no apparent effect on the time of nuclear transloca-
tion of Dnmt1o, inhibiting protein synthesis during the
four-cell stage accelerates the time for onset of blastomere
flattening (Levy et al., 1986). This finding provides further
evidence that, while the molecular pathways underlying
compaction and nuclear translocation of Dnmt1o may
share some components, they nevertheless are likely to
require distinct components.
Interestingly, the only other protein to our knowledge
that displays a transient nuclear localization during the
eight-cell stage is PKC-z (Pauken and Capco, 2000), which is
an atypical PKC in that it does not require either diacyl-
glycerol or calcium for activation of protein kinase activity.
Similar to Dnmt1o, inducing premature compaction by
treatment with phorbol diesters does not induce a preco-
cious PKC-z nuclear localization; it is not known whether
this transient nuclear localization is also linked to a “mo-
lecular clock.” In contrast to Dnmt1o, however, nuclear
retention of PKC-z is observed in permeabilized eight-cell
embryos (Pauken and Capco, 2000). Whether the nuclear
translocation of Dnmt1o and PKC-z are mechanistically
linked remains to be established.
Although Dnmt1o is again cytoplasmic following cleav-
age to the morula stage, it remains retained in the nucleus
in aphidicolin-treated, cleavage-arrested embryos that are
chronologically at the morula/blastocyst stage. While the
failure to translocate to the cytoplasm may reflect impaired
function of these embryos due to the prolonged inhibition
of DNA synthesis, it may also implicate a role for cell
division in the redistribution of Dnmt1o. Thus, nuclear
envelope breakdown may be required for the release of
Dnmt1o and its renewed cytoplasmic retention. Although
we have never observed nuclear loss in late stage eight-cell
embryos, it is possible that Dnmt1o is exported from the
eight-cell nuclei. Analysis of the real-time kinetics of
localization of a Dnmt1o–GFP fusion protein during the
eight-cell to morula transition could resolve this question.
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